InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

Current share price for HMD : $0.037 0.003 (8.82%)+

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$43 Cleansing Notice 17 Dec 2019 4:40PM $0.170 $0.037 fallen by 78.24%
$43 Appendix 3B 17 Dec 2019 4:38PM $0.170 $0.037 fallen by 78.24%
$43 Appendix 3B 12 Dec 2019 10:00AM $0.175 $0.037 fallen by 78.86%
$43 A$1.42m strategic placement completed to expedite US entry 10 Dec 2019 9:51AM $0.170 $0.037 fallen by 78.24%
$43 Trading Halt 6 Dec 2019 9:21AM $0.170 $0.037 fallen by 78.24%
$43 New CPT codes allow for potential reimbursement in USA 4 Dec 2019 8:25AM $0.180 $0.037 fallen by 79.44%
$43 2020 Company Outlook 2 Dec 2019 8:28AM $0.200 $0.037 fallen by 81.50%
$43 Change of Director's Interest Notice - Tal Slonim 28 Nov 2019 1:58PM $0.190 $0.037 fallen by 80.53%
$43 Change of Director's Interest Notice - David Groberman 28 Nov 2019 1:56PM $0.190 $0.037 fallen by 80.53%
$43 Appendix 3B and ASX Escrow Release 28 Nov 2019 1:46PM $0.190 $0.037 fallen by 80.53%
$43 Indian Hospital Group Cooperates with H-Cube and HeraMED 25 Nov 2019 9:16AM $0.215 $0.037 fallen by 82.79%
$43 Agreement adds telehealth services to Herabeat in Germany 21 Nov 2019 9:05AM $0.245 $0.037 fallen by 84.90%
$43 Release of Securities from ASX Escrow Restriction 20 Nov 2019 6:13PM n/a $0.037 n/a
$43 HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device 18 Nov 2019 8:57AM $0.215 $0.037 fallen by 82.79%
$43 Retraction of Statements - Next Tech Stock Article 15 Nov 2019 5:03PM $0.215 $0.037 fallen by 82.79%
$43 Trading Halt 15 Nov 2019 10:39AM $0.215 $0.037 fallen by 82.79%
$43 Pause in Trade 15 Nov 2019 10:01AM $0.215 $0.037 fallen by 82.79%
$43 Response to ASX Price and Volume Query 14 Nov 2019 3:24PM $0.195 $0.037 fallen by 81.03%
$43 Trading Halt 14 Nov 2019 12:33PM $0.195 $0.037 fallen by 81.03%
$43 Pause in Trading 14 Nov 2019 11:25AM $0.195 $0.037 fallen by 81.03%
$43 Hapvida Saude (Brazil) Trial Update 7 Nov 2019 9:09AM $0.160 $0.037 fallen by 76.88%
$43 Appendix 3B 5 Nov 2019 1:23PM $0.165 $0.037 fallen by 77.58%
$43 September Quarter Activities Report and Appendix 4C 30 Oct 2019 8:26AM $0.170 $0.037 fallen by 78.24%
$43 Market entry for HeraBEAT and HeraCARE Progresses in India 25 Oct 2019 8:48AM $0.165 $0.037 fallen by 77.58%
$43 HeraCARE - the digital era of pregnancy care 14 Oct 2019 8:30AM $0.160 $0.037 fallen by 76.88%

451 - 475 of 542 results

Page 19 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.